GH1 and in situ carcinoma: Indeed, when E2 was used in combination with GH, a 2-3-fold reduced mRNA expression levels of SOCS2 (Fig. 1D) and CIS (Fig.1E) were observed compared with GH treatment alone, again demonstrating the inhibitory actions of E2 on GH hepatic actions.